Nebulized Ensifentrine Suspension; 3 mg clinical trials

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

This study is testing a new medicine, ensifentrine, for people with a lung condition called non-cystic fibrosis bronchiectasis. We want to see if it helps reduce flare-ups, improve breathing, and make people feel better, compared to a dummy medicine.